Correction: Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy

Dayeon Yun; Hyun-Ouk Kim; Hye Young Son; Yuna Choi; Ilkoo Noh; Jong-Woo Lim; Jihye Kim; Haejin Chun; Geunseon Park; Dong Ki Lee; Sung Il Jang; Eunji Jang; Yong-Min Huh; Seungjoo Haam

doi:10.1039/c7tb90158e

Correction: Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy

J Mater Chem B. 2017 Nov 28;5(44):8879. doi: 10.1039/c7tb90158e. Epub 2017 Nov 7.

Authors

Dayeon Yun¹, Hyun-Ouk Kim, Hye Young Son, Yuna Choi, Ilkoo Noh, Jong-Woo Lim, Jihye Kim, Haejin Chun, Geunseon Park, Dong Ki Lee, Sung Il Jang, Eunji Jang, Yong-Min Huh, Seungjoo Haam

Affiliation

¹ Department of Chemical and Biomolecular Engineering, Yonsei University, Seoul 120-749, Republic of Korea. haam@yonsei.ac.kr.

PMID: 32264281
DOI: 10.1039/c7tb90158e

Abstract

Correction for 'Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy' by Dayeon Yun et al., J. Mater. Chem. B, 2017, 5, 6317-6324.